Personal prostate-specific antigen screening and treatment choices for localized prostate cancer among expert physicians

Abstract

Introduction: We aimed to determine the personal practices of urologists, radiation oncologists, and medical oncologists regarding prostate cancer screening and treatment using the physician surrogate method, which seeks to identify acceptable healthcare interventions by ascertaining interventions physicians select for themselves.Methods: A hierarchical, contingent survey was developed through a consensus involving urologists, medical oncologists, and radiation oncologists. It was piloted at the University of Toronto and then circulated to urologists, radiation oncologists, and medical oncologists through professional medical societies in the U.S., Canada, Central and South America, Australia, and New Zealand. The primary outcome was physicians’ personal choices regarding prostatespecific antigen (PSA) screening and the secondary outcome was treatment selection among those diagnosed with prostate cancer.Results: A total of 869 respondents provided consent and completed the survey. Of these, there were 719 urologists, 89 radiation oncologists, nine medical oncologists, and 53 undisclosed specialists. Most (784 of 869 respondents; 90%) endorsed past or future screening for themselves (among male physicians) or for relatives (among female physicians). Among urologists and radiation oncologists making prostate cancer treatment decisions, there was a significant correlation between physician specialty and the treatment selected (Phi coefficient=0.61; p=0.001).Conclusions: Physicians who routinely treat prostate cancer are likely to undertake prostate cancer screening themselves or recommend it for immediate family members. Treatment choice is influenced by the well-recognized specialty bias.

Radiation Oncologist Consultations Prior to Radical Prostatectomy: Disparities and Opportunities

“…7–9 While physician recommendations are often the most valued aspect of treatment decision making, 10 specialists also tend to recommend treatments performed by their own specialty. 11–14 Men are less likely to experience treatment regret when they feel fully informed of their prostate cancer treatment options, 15 highlighting the importance of multidisciplinary care.…”

Do Swiss urologists and Swiss internists screen themselves and their relatives for prostate cancer? A questionnaire study

“…Two recent studies investigated the selfscreening behaviour of physicians as a surrogate for their personal attitude towards PSA screening. A survey conducted among genitourinary cancer specialists in Canada, the United States, Australia, New Zealand, and Central and South America in 2018 showed a self-screening rate of 90% in physicians older than 55 years [22]. Although 896 physicians participated in the study, the response rate is unknown, so its results have to be interpreted with caution due to a possible selection bias.…”